The DOI matches its Crossref record; 235 of the 247 references it cites were found in a registry or an index.
Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives
Open accessAbstract
Due to improved phenotyping and genetic characterization, the field of 'incurable' and 'blinding' inherited retinal diseases (IRDs) has moved substantially forward. Decades of ascertainment of IRD patient data from Philadelphia and Toronto centers illustrate the progress from Mendelian genetic types to molecular diagnoses. Molecular genetics have been used not only to clarify diagnoses and to direct counseling but also to enable the first clinical trials of gene-based treatment in these diseases. An overview of the recent reports of gene augmentation clinical trials by subretinal injections is used to reflect on the reasons why there has been limited success in this early venture into therapy. These first-in human experiences have taught that there is a need for advancing the techniques of delivery of the gene products - not only for refining further subretinal trials, but also for evaluating intravitreal delivery. Candidate IRDs for intravitreal gene delivery are then suggested to illustrate some of the disorders that may be amenable to improvement of remaining central vision with the least photoreceptor trauma. A more detailed understanding of the human IRDs to be considered for therapy and the calculated potential for efficacy should be among the routine prerequisites for initiating a clinical trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“subfoveal viral gene therapy has been associated with various adverse effects, such as RPE alterations, retinal thinning, foveal morphological changes, vision loss, and the variable duration of clinical effects [281,294,296,297,298].”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [281]
Citations
Cites
Human photoreceptor topography
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902920402 · Cited by 2,792
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 1×
“The molecular mechanisms and human phenotypes of this group of diseases have been well explored and therapeutic concepts other than gene augmentation have been proposed and initiated (Allikmets et al., 1997; Sparrow et al., 1999; Fishman et al., 2003; Sears et al., 2017).”
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 2×
“This stimulated the interest of the more clinically-minded scientists; and, as such, translation to the clinic became imaginable (Acland et al., 2001, 2005; Cideciyan, 2010).”
Self-citationNon-syndromic retinitis pigmentosa
Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., Hoyng, C. B., Roepman, R., & Klevering, B. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.005 · Cited by 973
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Self-citationRpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929
Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat
D'Cruz, P. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.645 · Cited by 884
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 1×
“Lipofuscin accumulation in mouse models of ABCA4-STGD has been identified but the retinal degeneration that characterizes the human disease has not been a main finding (Weng et al., 1999; Zhang et al., 2015).”
Rickman, C. B., Li, T., Danciger, M., Baxter, L. C., Applebury, M., & Farber, D. B. (1990) · Nature · doi:10.1038/347677a0 · Cited by 852
INHERITED RETINAL DYSTROPHY IN THE RAT
Dowling, J. E., & Sidman, R. L. (1962) · The Journal of Cell Biology · doi:10.1083/jcb.14.1.73 · Cited by 803
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414221 · Cited by 743
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734 · cited 1×
“Intravitreal injections have the potential to transfect large retinal areas but experimental evidence in non-human primates indicates that penetration of current intravitreal vectors to photoreceptors would be mainly or only in the fovea (Dalkara et al., 2013; Boye et al., 2016; Khabou et al., 2018).”
Dark adaptation and the retinoid cycle of vision
Lamb, T. D., & Pugh, E. N. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.03.001 · Cited by 725
Gal, A., Li, Y., Thompson, D. A., Weir, J., Orth, U., Jacobson, S. G., Apfelstedt-Sylla, E., & Vollrath, D. (2000) · Nature Genetics · doi:10.1038/81555 · Cited by 679
Self-citationCideciyan, A. V., Alemán, T. S., Boye, S. L., Schwartz, S., Kaushal, S., Román, A. J., Pang, J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 674
Self-citationPhotoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., El-Aziz, M. M. A., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 668
Genes and mutations causing retinitis pigmentosa
Daiger, S. P., Sullivan, L. S., & Bowne, S. J. (2013) · Clinical Genetics · doi:10.1111/cge.12203 · Cited by 653
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Self-citationMutations in RPE65 cause Leber's congenital amaurosis
Marlhens, F., Bareil, C., Griffoin, J.-M., Zrenner, E., Amalric, P., Eliaou, C., Liu, S.-Y., Harris, E., Redmond, T. M., Arnaud, B., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-139 · Cited by 606
McLaughlin, M. E., Sandberg, M. A., Berson, E. L., & Dryja, T. P. (1993) · Nature Genetics · doi:10.1038/ng0693-130 · Cited by 602
Pittler, S. J., & Baehr, W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8322 · Cited by 562
Gene therapy: trials and tribulations
Somia, N., & Verma, I. M. (2000) · Nature Reviews Genetics · doi:10.1038/35038533 · Cited by 554
Meindl, A., Dry, K. L., Herrmann, K., Manson, F. D. C., Ciccodicola, A., Edgar, A. J., Carvalho, M. R. S., Achatz, H., Hellebrand, H., Lennon, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-35 · Cited by 480
Acland, G. M., Aguirre, G. K., Bennett, J., Alemán, T. S., Cideciyan, A. V., Bennicelli, J. L., Dejneka, N. S., Pearce-Kelling, S. E., Maguire, A. M., Palczewski, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.008 · Cited by 478
Self-citationStone, E. M., Andorf, J. L., Whitmore, S. S., DeLuca, A. P., Giacalone, J. C., Streb, L. M., Braun, T. A., Mullins, R. F., Scheetz, T. E., Sheffield, V. C., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.04.008 · Cited by 468
Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina.
Bunt-Milam, A. H., & Saari, J. C. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.3.703 · Cited by 455
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa
Vervoort, R., Lennon, A., Bird, A. C., TULLOCH, B. R., Axton, R. A., Miano, M. G., Meindl, A., Meitinger, T., Ciccodicola, A., & Wright, A. F. (2000) · Nature Genetics · doi:10.1038/78182 · Cited by 449
Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Świder, M., Iwabe, S., Román, A. J., Olivares, M. B., Schwartz, S., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 441
Self-citationMaguire, A. M., Russell, S., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., Marshall, K. A., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.06.017 · Cited by 409 · cited 3×
“, 2017) to support the conjecture that efficacy was durable (Maguire et al., 2019).”
Otto, E. A., Loeys, B., Khanna, H., Hellemans, J., Sudbrak, R., Fan, S., Muerb, U., O’Toole, J. F., Helou, J., Attanasio, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1520 · Cited by 399
Chang, B., Hawes, N. L., Pardue, M. T., German, A. M., Hurd, R. E., Davisson, M. T., Nusinowitz, S., Rengarajan, K., Boyd, A. P., Sidney, S. S., et al. (2007) · Vision Research · doi:10.1016/j.visres.2006.11.020 · Cited by 395
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
Jacobson, S. G., Cideciyan, A. V., Román, A. J., Sumaroka, A., Schwartz, S., Héon, E., & Hauswirth, W. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412965 · Cited by 370
Self-citationRetinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase
Seabra, M. C., Brown, M. S., & Goldstein, J. L. (1993) · Science · doi:10.1126/science.8380507 · Cited by 337
Hamel, C., Tsilou, E. T., Pfeffer, B. A., Hooks, J. J., Detrick, B., & Redmond, T. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82319-5 · Cited by 334
Kumaran, N., Moore, A. T., Weleber, R. G., & Michaelides, M. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309975 · Cited by 334
Cloning of a gene that is rearranged in patients with choroideraemia
Cremers, F. P. M., van de Pol, D. J. R., van Kerkhoff, L. P. M., Wieringa, B., & Ropers, H.-H. (1990) · Nature · doi:10.1038/347674a0 · Cited by 333
CNGA3 Mutations in Hereditary Cone Photoreceptor Disorders
Wissinger, B., Gamer, D., Jägle, H., Giorda, R., Marx, T., Mayer, S., Tippmann, S., Broghammer, M., Jurklies, B., Rosenberg, T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323613 · Cited by 329
Self-citationMaw, M. A., Kennedy, B. N., Knight, A., Bridges, R., Roth, K. E., Mani, E. J., Mukkadan, J. K., Nancarrow, D. J., Crabb, J. W., & Denton, M. J. (1997) · Nature Genetics · doi:10.1038/ng1097-198 · Cited by 325
Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
Bennett, J., Tanabe, T., Sun, D., Zeng, Y., Kjeldbye, H., Gouras, P., & Maguire, A. M. (1996) · Nature Medicine · doi:10.1038/nm0696-649 · Cited by 316
A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture.
Sparrow, J. R., Parish, C. A., Hashimoto, M., & Nakanishi, K. (1999) · PubMed · Cited by 310
Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk
Vollrath, D., Feng, W., Duncan, J. L., Yasumura, D., D'Cruz, P. M., Chappelow, A., Matthes, M. T., Kay, M. A., & LaVail, M. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221364198 · Cited by 290
Suber, M. L., Pittler, S. J., Qin, N., Wright, G. C., Holcombe, V., Lee, R. H., Craft, C. M., Lolley, R. N., Baehr, W., & Hurwitz, R. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3968 · Cited by 282
Jacobson, S. G., Alemán, T. S., Cideciyan, A. V., Sumaroka, A., Schwartz, S., Windsor, E. A. M., Traboulsi, E. I., Héon, E., Pittler, S. J., Milam, A. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500646102 · Cited by 276
Self-citationNrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
Yu, W., Mookherjee, S., Chaitankar, V., Hiriyanna, S., Kim, J.-W., Brooks, M., Ataeijannati, Y., Sun, X., Dong, L., Li, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14716 · Cited by 271
X-linked retinitis pigmentosa.
Bird, A. C. (1975) · British Journal of Ophthalmology · doi:10.1136/bjo.59.4.177 · Cited by 270
Cideciyan, A. V., Alemán, T. S., Świder, M., Schwartz, S., Steinberg, J. D., Brucker, A. J., Maguire, A. M., Bennett, J., Stone, E. M., & Jacobson, S. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh048 · Cited by 268
Self-citationReport from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium *
Csaky, K. G., Richman, E. A., & Ferris, F. L. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1132 · Cited by 265
An RCS-Like Retinal Dystrophy Phenotype in Mer Knockout Mice
Duncan, J. L., LaVail, M. M., Yasumura, D., Matthes, M. T., Yang, H., Trautmann, N., Chappelow, A. V., Feng, W., Earp, H. S., Matsushima, G. K., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0438 · Cited by 262
Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118847109 · Cited by 260
Self-citationLeber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
Cideciyan, A. V. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.002 · Cited by 256
Self-citationVan Hooser, J. P., Aleman, T. S., He, Y.-G., Cideciyan, A. V., Kuksa, V., Pittler, S. J., Stone, E. M., Jacobson, S. G., & Palczewski, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150236297 · Cited by 252
Self-citationCNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia
Kohl, S., Varsányi, B., Antunes, G. A., Baumann, B., Hoyng, C. B., Jägle, H., Rosenberg, T., Kellner, U., Lorenz, B., Salati, R., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201269 · Cited by 251
Self-citationSaari, J. C., Nawrot, M., Kennedy, B. N., Garwin, G. G., Hurley, J. B., Huang, J., Possin, D. E., & Crabb, J. W. (2001) · Neuron · doi:10.1016/s0896-6273(01)00248-3 · Cited by 250
Gal, A., Orth, U., Baehr, W., SCHWINGER, E., & Rosenberg, T. (1994) · Nature Genetics · doi:10.1038/ng0594-64 · Cited by 245
Breuer, D. K., Yashar, B. M., Filippova, E. V., Hiriyanna, S., Lyons, R. H., Mears, A. J., Asaye, B., Acar, C., Vervoort, R., Wright, A. F., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340848 · Cited by 245
Self-citationGlöckle, N., Kohl, S., Mohr, J., Scheurenbrand, T., Sprecher, A., Weisschuh, N., Bernd, A. S., Rudolph, G., Schubach, M., Poloschek, C. M., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.72 · Cited by 243
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1637-y · Cited by 243 · cited 2×
“Efficacy outcomes used in the trial mirrored those in the RPE65-LCA trials (Ghazi et al., 2016).”
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Duncan, J., Pierce, E., Laster, A., Daiger, S. P., Birch, D., Ash, J., Iannaccone, A., Flannery, J., Sahel, J., Zack, D., et al. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.4.6 · Cited by 228
Jacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224
Self-citationCideciyan, A. V., Jacobson, S. G., Drack, A. V., Ho, A. C., Charng, J., Garafalo, A. V., Román, A. J., Sumaroka, A., Han, I. C., Hochstedler, M. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0295-0 · Cited by 223
Self-citationGene therapy rescues cone function in congenital achromatopsia
Komáromy, A. M., Alexander, J. J., Rowlan, J. S., Garcia, M. M., Chiodo, V. A., Kaya, A., Tanaka, J. C., Acland, G. M., Hauswirth, W. W., & Aguirre, G. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq136 · Cited by 217
Self-citationKong, J., Kim, S.-R., Binley, K. E., Pata, I., Doi, K., Männik, J., Zernant-Rajang, J., Kan, O., Iqball, S., Naylor, S., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.78 · Cited by 214
Huang, X., Huang, F., Wu, K.-C., Wu, J., Chen, J., Pang, C. P., Lü, F., Qu, J., & Jin, Z. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.138 · Cited by 211
Birch, D. G., Locke, K. G., Wen, Y., Locke, K. I., Hoffman, D. R., & Hood, D. C. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4160 · Cited by 199
Visual Acuity after Retinal Gene Therapy for Choroideremia
Edwards, T. L., Jolly, J. K., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Black, G. C., Webster, A. R., Lotery, A. J., Holder, G. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1509501 · Cited by 195
Fishman, G. A. (1978) · Archives of Ophthalmology · doi:10.1001/archopht.1978.03910050428005 · Cited by 190
ABCA4 disease progression and a proposed strategy for gene therapy
Cideciyan, A. V., Swider, M., Aleman, T. S., Tsybovsky, Y., Schwartz, S. B., Windsor, E. A. M., Roman, A. J., Sumaroka, A., Steinberg, J. D., Jacobson, S. G., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn421 · Cited by 186
Self-citationBeneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Xue, K., Jolly, J. K., Barnard, A. R., Rudenko, A., Salvetti, A. P., Patrício, M. I., Edwards, T. L., Groppe, M., Orlans, H. O., Tolmachova, T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0185-5 · Cited by 185
Audo, I. S., Bujakowska, K. M., Léveillard, T., Mohand‐Saïd, S., Lancelot, M., Germain, A., Antonio, A., Michiels, C., Saraiva, J., Letexier, M., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-8 · Cited by 181
On the heredity of retinitis pigmentosa.
Jay, M. (1982) · British Journal of Ophthalmology · doi:10.1136/bjo.66.7.405 · Cited by 180
Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience
Dimopoulos, I. S., Hoang, S. C., Radziwon, A., Binczyk, N. M., Seabra, M. C., MacLaren, R. E., Somani, R., Tennant, M. T. S., & MacDonald, I. M. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.06.011 · Cited by 175
Remodeling of the Human Retina in Choroideremia: Rab Escort Protein 1 ( REP-1 ) Mutations
Jacobson, S. G., Cideciyan, A. V., Sumaroka, A., Alemán, T. S., Schwartz, S., Windsor, E. A. M., Román, A. J., Stone, E. M., & MacDonald, I. M. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0424 · Cited by 173
Self-citationCarvalho, L. S., Xu, J., Pearson, R. A., Smith, A. J., Bainbridge, J. W., Morris, L. M., Fliesler, S. J., Ding, X., & Ali, R. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr218 · Cited by 173
Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice
Liu, X., Ondek, B., & Williams, D. S. (1998) · Nature Genetics · doi:10.1038/470 · Cited by 168
Román, A. J., Schwartz, S., Alemán, T. S., Cideciyan, A. V., Chico, J. D., Windsor, E. A. M., Gardner, L. M., Ying, G., Smilko, E. E., Maguire, M. G., et al. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.09.008 · Cited by 165
Self-citationMutation Analysis of 3 Genes in Patients With Leber Congenital Amaurosis
Lotery, A. J. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.4.538 · Cited by 163
Choroideremia gene therapy phase 2 clinical trial: 24-month results
Lam, B. L., Davis, J. L., Gregori, N. Z., MacLaren, R. E., Girach, A., Verriotto, J. D., Rodriguez, B., Rosa, P. R., Zhang, X., & Feuer, W. J. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.09.012 · Cited by 161
Ellingford, J. M., Barton, S., Bhaskar, S. S., Williams, S. G., Sergouniotis, P. I., O’Sullivan, J., Lamb, J. A., Perveen, R., Hall, G., Newman, W. G., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.009 · Cited by 160
Cideciyan, A. V., Alemán, T. S., Jacobson, S. G., Khanna, H., Sumaroka, A., Aguirre, G. K., Schwartz, S., Windsor, E. A. M., He, S., Chang, B., et al. (2007) · Human Mutation · doi:10.1002/humu.20565 · Cited by 157
Self-citationBramall, A. N., Wright, A. F., Jacobson, S. G., & McInnes, R. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153227 · Cited by 152
Self-citationMorimura, H., Berson, E. L., & Dryja, T. P. (1999) · PubMed · Cited by 147
Jacobson, S. G., Boye, S. L., Alemán, T. S., Conlon, T. J., Zeiss, C. J., Román, A. J., Cideciyan, A. V., Schwartz, S., Komáromy, A. M., Doobrajh, M., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.845 · Cited by 145
Self-citationAAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye
Reichel, F. F., Dauletbekov, D. L., Klein, R., Peters, T., Ochakovski, G. A., Seitz, I. P., Wilhelm, B., Ueffing, M., Biel, M., Wissinger, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.018 · Cited by 145
Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations
Cideciyan, A. V., Świder, M., Alemán, T. S., Román, M. I., Sumaroka, A., Schwartz, S., Stone, E. M., & Jacobson, S. G. (2007) · Journal of the Optical Society of America A · doi:10.1364/josaa.24.001457 · Cited by 144
Self-citationAAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
Smith, A. J., Schlichtenbrede, F. C., Tschernutter, M., Bainbridge, J. W., Thrasher, A. J., & Ali, R. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00144-8 · Cited by 141
Pang, J., Boye, S. L., Kumar, A., Dinculescu, A., Deng, W., Li, J., Li, Q., Rani, A., Foster, T. C., Chang, B., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1622 · Cited by 138
Tolmachova, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26617 · Cited by 133
Diagnostic exome sequencing in 266 Dutch patients with visual impairment
Haer‐Wigman, L., van Zelst–Stams, W. A. G., Pfundt, R., van den Born, L. I., Klaver, C. C. W., Verheij, J. B., Hoyng, C. B., Breuning, M. H., Boon, C. J. F., Kievit, A. J. A., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.9 · Cited by 133
Mutations in RPGR and RP2 Account for 15% of Males with Simplex Retinal Degenerative Disease
Branham, K. E. H., Othman, M., Brumm, M. V., Karoukis, A. J., Atmaca-Sönmez, P., Yashar, B. M., Schwartz, S., Stover, N. B., Trzupek, K. M., Wheaton, D. K., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11025 · Cited by 131
Self-citationX-linked Retinitis Pigmentosa Profile of Clinical Findings
Fishman, G. A., Farber, M. D., & Derlacki, D. J. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130395029 · Cited by 128
Dyka, F. M., Boye, S. L., Chiodo, V. A., Hauswirth, W. W., & Boye, S. E. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.212 · Cited by 128
Burstedt, M. S. I., Sandgren, O., Holmgren, G., & Forsman‐Semb, K. (1999) · PubMed · Cited by 126
The β subunit of cyclic GMP phosphodiesterase mRNA is deficient in canine rod-cone dysplasia 1
Farber, D. B., Danciger, J. S., & Aguirre, G. K. (1992) · Neuron · doi:10.1016/0896-6273(92)90173-b · Cited by 125
Self-citationCRALBP supports the mammalian retinal visual cycle and cone vision
Xue, Y., Shen, S. Q., Jui, J., Rupp, A. C., Byrne, L. C., Hattar, S. S., Flannery, J. G., Corbo, J. C., & Kefalov, V. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79651 · Cited by 125
Noninvasive gene delivery to foveal cones for vision restoration
Khabou, H., Garita-Hernandez, M., Chaffiol, A., Reichman, S., Jaillard, C., Brazhnikova, E., Bertin, S., Forster, V., Desrosiers, M., Winckler, C., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96029 · Cited by 124
Seeing the light after 25 Years of retinal gene therapy
Trapani, I., & Auricchio, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.006 · Cited by 124
High-Resolution Adaptive Optics Retinal Imaging of Cellular Structure in Choroideremia
Morgan, J. I. W., Han, G., Klinman, E., Maguire, W., Chung, D. C., Maguire, A. M., & Bennett, J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13454 · Cited by 123
Restoration of visual function by transplantation of optogenetically engineered photoreceptors
Garita‐Hernandez, M., Lampič, M., Chaffiol, A., Guibbal, L., Routet, F., Santos‐Ferreira, T., Gasparini, S. J., Borsch, O., Gagliardi, G., Reichman, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12330-2 · Cited by 123
Defining the Residual Vision in Leber Congenital Amaurosis Caused by RPE65 Mutations
Jacobson, S. G., Aleman, T. S., Cideciyan, A. V., Roman, A. J., Sumaroka, A., Windsor, E. A. M., Schwartz, S. B., Heon, E., & Stone, E. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2696 · Cited by 121
Self-citationAmmann, F., Klein, D. C., & Franceschetti, A. T. (1965) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(65)90079-1 · Cited by 121
Cideciyan, A. V., Świder, M., Alemán, T. S., Feuer, W. J., Schwartz, S., Russell, R. C., Steinberg, J. D., Stone, E. M., & Jacobson, S. G. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8415 · Cited by 119
Self-citationNatural History of the Central Structural Abnormalities in Choroideremia
Alemán, T. S., Han, G., Serrano, L. W., Fuerst, N. M., Charlson, E. S., Pearson, D. J., Chung, D. C., Traband, A., Pan, W., Ying, G., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.10.022 · Cited by 119
Román, A. J., Cideciyan, A. V., Alemán, T. S., & Jacobson, S. G. (2007) · Physiological Measurement · doi:10.1088/0967-3334/28/8/n02 · Cited by 118
Self-citationUsher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism
Jacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Román, A. J., Gardner, L. M., Prosser, H. M., Mishra, M., Bech‐Hansen, N. T., Herrera, W., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn140 · Cited by 118
Self-citationCideciyan, A. V., Rachel, R. A., Alemán, T. S., Świder, M., Schwartz, S., Sumaroka, A., Román, A. J., Stone, E. M., Jacobson, S. G., & Swaroop, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr022 · Cited by 117
Self-citationAchromatopsia: clinical features, molecular genetics, animal models and therapeutic options
Hirji, N., Aboshiha, J., Georgiou, M., Bainbridge, J. W., & Michaelides, M. (2018) · Ophthalmic Genetics · doi:10.1080/13816810.2017.1418389 · Cited by 116
Binley, K., Widdowson, P., Loader, J., Kelleher, M., Iqball, S., Ferrige, G., de Belin, J., Carlucci, M., Angell-Manning, D., Hurst, F., et al. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11871 · Cited by 115
Residual Foveal Cone Structure in CNGB3 -Associated Achromatopsia
Langlo, C. S., Patterson, E. J., Higgins, B. P., Summerfelt, P., Razeen, M. M., Erker, L. R., Parker, M., Collison, F. T., Fishman, G. A., Kay, C. N., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19313 · Cited by 114
Banin, E., Gootwine, E., Obolensky, A., Ezra-Elia, R., Ejzenberg, A., Zelinger, L., Honig, H., Rosov, A., Yamin, E., Sharon, D., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.114 · Cited by 113
IQCB1 Mutations in Patients with Leber Congenital Amaurosis
Estrada‐Cuzcano, A., Koenekoop, R. K., Coppieters, F., Kohl, S., López, I., Collin, R. W. J., Baere, E. B. W. D., Roeleveld, D. M., Marek, J., Bernd, A. S., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5221 · Cited by 113
Self-citationFischer, M. D., McClements, M. E., Martinez-Fernandez de la Camara, C., Bellingrath, J.-S., Dauletbekov, D., Ramsden, S. C., Hickey, D. G., Barnard, A. R., & MacLaren, R. E. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.005 · Cited by 112
Human Cone Visual Pigment Deletions Spare Sufficient Photoreceptors to Warrant Gene Therapy
Cideciyan, A. V., Hufnagel, R. B., Carroll, J., Sumaroka, A., Luo, X., Schwartz, S., Dubra, A., Land, M. E., Michaelides, M., Gardner, J. C., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.153 · Cited by 109
Self-citationEvaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia
Syed, N. A., Smith, J. E., John, S. K., Seabra, M. C., Aguirre, G. K., & Milam, A. H. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00643-6 · Cited by 105
Self-citationZallocchi, M., Binley, K., Lad, Y., Ellis, S., Widdowson, P. S., Iqball, S., Scripps, V., Kelleher, M., Loader, J., Miskin, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094272 · Cited by 104
Gene therapy for visual loss: Opportunities and concerns
Lee, J. H., Wang, J.-H., Chen, J., Li, F., Edwards, T. L., Hewitt, A. W., & Liu, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.08.003 · Cited by 103
High-Resolution Images of Retinal Structure in Patients with Choroideremia
Syed, R., Sundquist, S. M., Ratnam, K., Zayit‐Soudry, S., Zhang, Y., Crawford, J. B., MacDonald, I. M., Godara, P., Rha, J., Carroll, J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10707 · Cited by 101
A genetic analysis of retinitis pigmentosa.
Boughman, J. A., & Fishman, G. A. (1983) · British Journal of Ophthalmology · doi:10.1136/bjo.67.7.449 · Cited by 101
Photoreceptor Layer Topography in Children with Leber Congenital Amaurosis Caused by RPE65 Mutations
Jacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Windsor, E. A. M., Schwartz, S., Héon, E., & Stone, E. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2121 · Cited by 101
Self-citationEichers, E. R., Green, J. S., Stockton, D. W., Jackman, C. S., Whelan, J., McNamara, J. A., Johnson, G. J., Lupski, J. R., & Katsanis, N. (2002) · The American Journal of Human Genetics · doi:10.1086/339688 · Cited by 101
Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations
Zhang, N., Tsybovsky, Y., Kolesnikov, A. V., Rôżanowska, M., Świder, M., Schwartz, S., Stone, E. M., Palczewska, G., Maeda, A., Kefalov, V. J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv073 · Cited by 100
Self-citationConlon, T. J., Deng, W., Erger, K. E., Cossette, T. L., Pang, J., Ryals, R. C., Clément, N., Cleaver, B. D., McDoom, I., Boye, S. L., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.037 · Cited by 99
Cremers, F. P. M., Boon, C. J. F., Bujakowska, K. M., & Zeitz, C. (2018) · Genes · doi:10.3390/genes9040215 · Cited by 99
Khan, N. W., Wissinger, B., Kohl, S., & Sieving, P. A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1521 · Cited by 97
Toward an elucidation of the molecular genetics of inherited retinal degenerations
Farrar, G. J., Carrigan, M., Dockery, A., Millington‐Ward, S., Palfi, A., Chadderton, N., Humphries, M. M., Kiang, A. S., Kenna, P. F., & Humphries, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx185 · Cited by 97
Beltran, W. A., Cideciyan, A. V., Iwabe, S., Świder, M., Kosyk, M. S., McDaid, K. S., Martynyuk, I., Ying, G., Shaffer, J., Deng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509914112 · Cited by 94
Self-citationDisease Boundaries in the Retina of Patients with Usher Syndrome Caused by MYO7A Gene Mutations
Jacobson, S. G., Aleman, T. S., Sumaroka, A., Cideciyan, A. V., Roman, A. J., Windsor, E. A. M., Schwartz, S. B., Rehm, H. L., & Kimberling, W. J. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3122 · Cited by 93
Self-citationABCA4 Gene Sequence Variations in Patients With Autosomal Recessive Cone-Rod Dystrophy
Fishman, G. A. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.851 · Cited by 93
Tolmachova, T., Tolmachov, O. E., Barnard, A. R., Silva, S. R. D., Lipinski, D. M., Walker, N. J., MacLaren, R. E., & Seabra, M. C. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1006-4 · Cited by 92
Tolmachova, T., Wavre‐Shapton, S. T., Barnard, A. R., MacLaren, R. E., Futter, C. E., & Seabra, M. C. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4892 · Cited by 92
Fischer, M. D., Ochakovski, G. A., Beier, B., Seitz, I. P., Vaheb, Y., Kortuem, C., Reichel, F. F. L., Kuehlewein, L., Kahle, N. A., Peters, T., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.3278 · Cited by 92
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period
Strauss, R. W., Kong, X., Ho, A., Jha, A., West, S. K., Ip, M. S., Bernstein, P. S., Birch, D. G., Cideciyan, A. V., Michaelides, M., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.2885 · Cited by 85
Self-citationGenetic aspects of retinitis pigmentosa in China
Hu, D. (1982) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320120107 · Cited by 84
Komáromy, A. M., Rowlan, J. S., Corr, A. T. P., Reinstein, S. L., Boye, S. L., Cooper, A. E., Gonzalez, A., Levy, B. J., Wen, R., Hauswirth, W. W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.50 · Cited by 83
Self-citationRetinal Disease Course in Usher Syndrome 1B Due to MYO7A Mutations
Jacobson, S. G., Cideciyan, A. V., Gibbs, D., Sumaroka, A., Román, A. J., Alemán, T. S., Schwartz, S., Olivares, M. B., Russell, R. C., Steinberg, J. D., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8313 · Cited by 83
Self-citationAAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models
Vasireddy, V., Mills, J. A., Gaddameedi, R., Basner‐Tschakarjan, E., Köhnke, M., Black, A. D., Alexandrov, K. A., Zhou, S., Maguire, A. M., Chung, D. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061396 · Cited by 83
Johnson, S. J., Buessing, M. G., O’Connell, T., Pitluck, S., & Ciulla, T. A. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.2512 · Cited by 82
Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina
Boye, S. L., Alexander, J. J., Witherspoon, C. D., Boye, S. L., Peterson, J. J., Clark, M. E., Sandefer, K. J., Girkin, C. A., Hauswirth, W. W., & Gamlin, P. D. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.085 · Cited by 81
Pawlyk, B. S., Bulgakov, O. V., Liu, X., Xu, X., Adamian, M., Sun, X., Khani, S. C., Berson, E. L., Sandberg, M. A., & Li, T. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.218 · Cited by 78
Birch, D. G., Locke, K. G., Felius, J., Klein, M., Wheaton, D. K., Hoffman, D. R., & Hood, D. C. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.11.005 · Cited by 78
LaVail, M. M. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)31048-8 · Cited by 75
Visual Function and Central Retinal Structure in Choroideremia
Héon, E., Alabduljalil, T., McGuigan, D. B., Cideciyan, A. V., Li, S., Chen, S., & Jacobson, S. G. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18421 · Cited by 74
Self-citationThe many different cellular functions of MYO7A in the retina
Williams, D. S., & Lopes, V. S. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391207 · Cited by 73
Genetics and Disease Expression in the CNGA3 Form of Achromatopsia
Zelinger, L., Cideciyan, A. V., Kohl, S., Schwartz, S., Rosenmann, A., Eli, D., Sumaroka, A., Román, A. J., Luo, X., Brown, C. J., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.11.025 · Cited by 72
Self-citationComprehensive Analysis of the Achromatopsia Genes CNGA3 and CNGB3 in Progressive Cone Dystrophy
Thiadens, A. A. H. J., Roosing, S., Collin, R. W. J., van Moll-Ramirez, N., van Lith-Verhoeven, J. J. C., van Schooneveld, M. J., den Hollander, A. I., van den Born, L. I., Hoyng, C. B., Cremers, F. P. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.09.008 · Cited by 72
MERTK mutation update in inherited retinal diseases
Audo, I. S., Mohand‐Saïd, S., Boulanger-Scemama, É., Zanlonghi, X., Condroyer, C., Démontant, V., Boyard, F., Antonio, A., Méjécase, C., Shamieh, S. E., et al. (2018) · Human Mutation · doi:10.1002/humu.23431 · Cited by 72
Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration
Davis, J. L., Gregori, N. Z., MacLaren, R. E., & Lam, B. L. (2019) · Retina · doi:10.1097/iae.0000000000002609 · Cited by 72
A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration
Wu, Z., Hiriyanna, S., Qian, H., Mookherjee, S., Campos, M. M., Gao, C., Fariss, R. N., Sieving, P. A., Li, T., Colosi, P., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv134 · Cited by 71
Gene and cell‐based therapies for inherited retinal disorders: An update
Sengillo, J. D., Justus, S., Tsai, Y., Cabral, T., & Tsang, S. H. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31534 · Cited by 70
Sears, A. E., Bernstein, P. S., Cideciyan, A. V., Hoyng, C. B., Issa, P. C., Palczewski, K., Rosenfeld, P. J., Sadda, S. R., Schraermeyer, U., Sparrow, J. R., et al. (2017) · Translational Vision Science & Technology · doi:10.1167/tvst.6.5.6 · Cited by 70
Self-citationLeber Congenital Amaurosis (LCA): Potential for Improvement of Vision
Cideciyan, A. V., & Jacobson, S. G. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-26672 · Cited by 69
Self-citationRestoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy
Petit, L., Lhériteau, E., Weber, M., Meur, G. L., Deschamps, J., Provost, N., Mendes-Madeira, A., Libeau, L., Guihal, C., Colle, M.-A., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.134 · Cited by 68
Stone, E. M. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.330 · Cited by 68
Panel-Based Population Next-Generation Sequencing for Inherited Retinal Degenerations
Carrigan, M., Duignan, E. S., Malone, C. P., Stephenson, K. A. J., Saad, T., McDermott, C., Green, A., Keegan, D., Humphries, P., Kenna, P. F., et al. (2016) · Scientific Reports · doi:10.1038/srep33248 · Cited by 68
Long-term Structural Outcomes of Late-stage RPE65 Gene Therapy
Gardiner, K. L., Cideciyan, A. V., Swider, M., Dufour, V. L., Sumaroka, A., Komáromy, A. M., Hauswirth, W. W., Iwabe, S., Jacobson, S. G., Beltran, W. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.013 · Cited by 67
Self-citationHamel, C., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Redmond, T. M. (1994) · Genomics · doi:10.1006/geno.1994.1212 · Cited by 66
Changes in Retinal Sensitivity after Gene Therapy in Choroideremia
Fischer, M. D., Ochakovski, G. A., Beier, B., Seitz, I. P., Vaheb, Y., Kortuem, C., Reichel, F. F. L., Kuehlewein, L., Kahle, N. A., Peters, T., et al. (2020) · Retina · doi:10.1097/iae.0000000000002360 · Cited by 66
RPGR- Associated Retinal Degeneration in Human X-Linked RP and a Murine Model
Huang, W. C., Wright, A. F., Román, A. J., Cideciyan, A. V., Manson, F. D. C., Gewaily, D. Y., Schwartz, S., Sadigh, S., Limberis, M. P., Bell, P. L., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10070 · Cited by 65
Self-citationYe, G.-J., Budzynski, E., Sonnentag, P., Nork, T. M., Miller, P. E., Sharma, A. K., Ver Hoeve, J. N., Smith, L. M., Arndt, T., Calcedo, R., et al. (2016) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.164 · Cited by 64
Issa, P. C., Bolz, H. J., Ebermann, I., Domeier, E., Holz, F. G., & Scholl, H. P. N. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.147397 · Cited by 63
Gene Therapy in the Post-Gelsinger Era
Smith, L., & Byers, J. F. (2002) · JONA s Healthcare Law Ethics and Regulation · doi:10.1097/00128488-200212000-00004 · Cited by 62
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
Mitsios, A., Dubis, A. M., & Moosajee, M. (2018) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841418817490 · Cited by 62
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA
Langlo, C. S., Erker, L. R., Parker, M., Patterson, E. J., Higgins, B. P., Summerfelt, P., Razeen, M. M., Collison, F. T., Fishman, G. A., Kay, C. N., et al. (2017) · Retina · doi:10.1097/iae.0000000000001434 · Cited by 61
Ramlogan‐Steel, C. A., Murali, A., Andrzejewski, S., Dhungel, B. P., Steel, J. C., & Layton, C. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13416 · Cited by 60
Inner and Outer Retinal Changes in Retinal Degenerations Associated With ABCA4 Mutations
Huang, W. C., Cideciyan, A. V., Román, A. J., Sumaroka, A., Sheplock, R., Schwartz, S., Stone, E. M., & Jacobson, S. G. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13768 · Cited by 58
Self-citationGene therapy for the treatment of X-linked retinitis pigmentosa
de la Cámara, C. M.-F., Nanda, A., Salvetti, A. P., Fischer, M. D., & MacLaren, R. E. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1444476 · Cited by 58
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
Zimmermann, M. R., Lubinga, S. J., Banken, R., Rind, D. M., Cramer, G., Synnott, P. G., Chapman, R. H., Khan, S., & Carlson, J. J. (2018) · Value in Health · doi:10.1016/j.jval.2018.09.2841 · Cited by 58
Retinal degenerations in the dog. I. Rod dysplasia
Aguirre, G. D. (1978) · Experimental Eye Research · doi:10.1016/0014-4835(78)90072-6 · Cited by 57
Self-citationZobor, D., Werner, A., Stanzial, F., Benedicenti, F., Rudolph, G., Kellner, U., Hamel, C., Andréasson, S., Zobor, G., Straßer, T., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20427 · Cited by 57
Dyka, F. M., Molday, L. L., Chiodo, V. A., Molday, R. S., & Hauswirth, W. W. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.132 · Cited by 56
The Death of Jesse Gelsinger: New Evidence of the Influence of Money and Prestige in Human Research
Wilson, R. F. (2010) · American Journal of Law & Medicine · doi:10.1177/009885881003600202 · Cited by 55
Tyrosine-Mutant AAV8 Delivery of Human MERTK Provides Long-Term Retinal Preservation in RCS Rats
Deng, W., Dinculescu, A., Li, Q., Boye, S. L., Li, J., Gorbatyuk, M. S., Pang, J., Chiodo, V. A., Matthes, M. T., Yasumura, D., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8831 · Cited by 55
A Novel Mutation and Phenotypes in Phosphodiesterase 6 Deficiency
Tsang, S. H., Tsui, I., Chou, C. L., Zernant, J., Haamer, E., IRANMANESH, R., Tosi, J., & Allikmets, R. L. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.06.017 · Cited by 55
Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa
Deng, W., Dyka, F. M., Dinculescu, A., Li, J., Zhu, P., Chiodo, V. A., Boye, S. L., Conlon, T. J., Erger, K. E., Cossette, T. L., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.035 · Cited by 55
Michaelides, M. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.11.1317 · Cited by 53
Bernardis, I., Chiesi, L., Tenedini, E., Artuso, L., Percesepe, A., Artusi, V., Simone, M. L., Manfredini, R., Camparini, M., Rinaldi, C., et al. (2016) · BioMed Research International · doi:10.1155/2016/6341870 · Cited by 51
AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs
Pichard, V., Provost, N., Mendes-Madeira, A., Libeau, L., Hulin, P., Tshilenge, K., Biget, M., Ameline, B., Deschamps, J., Weber, M., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.37 · Cited by 50
TULP1 Mutations Causing Early-Onset Retinal Degeneration: Preserved but Insensitive Macular Cones
Jacobson, S. G., Cideciyan, A. V., Huang, W., Sumaroka, A., Román, A. J., Schwartz, S., Luo, X., Sheplock, R., Dauber, J. M., Świder, M., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14570 · Cited by 47
Self-citationCideciyan, A. V., Świder, M., Schwartz, S., Stone, E. M., & Jacobson, S. G. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17698 · Cited by 47
Self-citationPennesi, M. E., Birch, D. G., Duncan, J. L., Bennett, J., & Girach, A. (2019) · Retina · doi:10.1097/iae.0000000000002553 · Cited by 45
Peng, Y., Zallocchi, M., Wang, W., Delimont, D. C., & Cosgrove, D. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6557 · Cited by 44
Gene Therapy for MERTK-Associated Retinal Degenerations
LaVail, M. M., Yasumura, D., Matthes, M. T., Yang, H., Hauswirth, W. W., Deng, W., & Vollrath, D. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_65 · Cited by 43
Wright, A. F., Bhattacharya, S. S., Clayton, J. F., Dempster, M., Tippett, P., McKeown, C., Jay, M., Jay, B., & Bird, A. C. (1987) · Europe PMC (PubMed Central) · Cited by 42
Gene therapy for achromatopsia
Michalakis, S., Schön, C., Becirovic, E., & Biel, M. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2944 · Cited by 41
Ervin, A., Strauss, R. W., Ahmed, M. I., Birch, D. G., Cheetham, J. K., Ferris, F. L., Ip, M. S., Jaffe, G. J., Maguire, M. G., Schönbach, E. M., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.2.16 · Cited by 41
Downs, L. M., Scott, E. M., Cideciyan, A. V., Iwabe, S., Dufour, V., Gardiner, K. L., Genini, S., Marinho, L. F., Sumaroka, A., Kosyk, M. S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw254 · Cited by 40
Self-citationNonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa
MacLachlan, T. K., Milton, M. N., Turner, O., Tukov, F., Choi, V. W., Penraat, J., Hanks, S. M., Vrouvlianis, J., Leehy, B., Li, H., et al. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.12.001 · Cited by 40
Gene Therapy for Color Blindness.
Hassall, M., Barnard, A. R., & MacLaren, R. E. (2017) · PubMed · Cited by 40
Achromatopsia: On the Doorstep of a Possible Therapy
Zobor, D., Zobor, G., & Kohl, S. (2015) · Ophthalmic Research · doi:10.1159/000435957 · Cited by 38
Retinal Morphology of Patients With Achromatopsia During Early Childhood
Yang, P. G., Michaels, K. V., Courtney, R. J., Wen, Y., Greninger, D. A., Reznick, L. G., Karr, D. J., Wilson, L. B., Weleber, R. G., & Pennesi, M. E. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.685 · Cited by 38
Sumaroka, A., Garafalo, A. V., Semenov, E. P., Sheplock, R., Krishnan, A. K., Román, A. J., Jacobson, S. G., & Cideciyan, A. V. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27156 · Cited by 38
Self-citationEvidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation
Jacobson, S. G., Sumaroka, A., Aleman, T. S., Cideciyan, A. V., Danciger, M., & Farber, D. B. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.104463 · Cited by 37
Self-citationRetinal Degeneration in Choroideremia follows an Exponential Decay Function
Aylward, J. W., Xue, K., Patrício, M. I., Jolly, J. K., Wood, J. C., Brett, J., Jasani, K., & MacLaren, R. E. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.02.004 · Cited by 37
De Novo Mutation in the RP1 Gene (Arg677ter) Associated with Retinitis Pigmentosa
Schwartz, S., Alemán, T. S., Cideciyan, A. V., Swaroop, A., Jacobson, S. G., & Stone, E. M. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0155 · Cited by 36
Self-citationHereditary aspects of pigmentary retinopathy.
Jay, B. (1972) · PubMed · Cited by 36
Charng, J., Cideciyan, A. V., Jacobson, S. G., Sumaroka, A., Schwartz, S., Świder, M., Román, A. J., Sheplock, R., Anand, M., Peden, M. C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw361 · Cited by 36
Self-citation
Research works printed but not linked: 3
- Green, 2017, Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective natural history study, Investig. Ophthalmol. Vis. Sci., 58, 3254
- Iannaccone, 2005, The genetics of hereditary retinopathies and optic neuropathies, Compr. Ophthalmol. Update, 6, 39
- Ni, 2017, Full-field stimulus threshold dark-adaptation kinetics over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective natural history study, Investig. Ophthalmol. Vis. Sci., 58, 3249
Cited by
Sorted by citations
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Herrera‐Barrera, M., Ryals, R. C., Gautam, M., Jozić, A., Landry, M. R., Korzun, T., Gupta, M., Acosta, C., Stoddard, J., Reynaga, R., et al. (2023) · Science Advances · doi:10.1126/sciadv.add4623 · Cited by 248
Schneider, N., Sundaresan, Y., Gopalakrishnan, P., Beryozkin, A., Hanany, M., Levanon, E. Y., Banin, E., Ben‐Aroya, S., & Sharon, D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101029 · Cited by 231
Mechanisms of Photoreceptor Death in Retinitis Pigmentosa
Newton, F. G., & Megaw, R. D. (2020) · Genes · doi:10.3390/genes11101120 · Cited by 210
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy
Maguire, A. M., Bennett, J., Aleman, E. M., Leroy, B. P., & Alemán, T. S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.029 · Cited by 189
Metadata
- Authors
- Garafalo, A. V., Cideciyan, A. V., Héon, E., Sheplock, R., Pearson, A., WeiYang Yu, C., Sumaroka, A., Aguirre, G. D., & Jacobson, S. G.
- Affiliations
- University of Pennsylvania (US)
- University of Toronto (CA)
- Corresponding author
- Jacobson, Samuel G.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 77
- Pages
- 100827
- ISSN
- 1350-9462 (ISSN-L)
- PMC
- PMC8714059
- OpenAlex
- W2996789825
- Cited by
- 173
- References
- 247
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 26 · 2022: 28 · 2021: 48 · 2020: 27
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Progress in Retinal and Eye Research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health/National Eye Institute (EY-017549)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- inherited retinal disease, subretinal gene therapy, gene augmentation, clinical trials, intravitreal gene delivery, molecular diagnosis, genetic counseling, photoreceptors, retinal degeneration
- MeSH terms
- Clinical Trials as Topic, Humans, Retinal Degeneration, Retinitis Pigmentosa, Genetic Therapy, Eye Diseases, Hereditary, Gene Transfer Techniques, Leber Congenital Amaurosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review